Effect of (Z)-isomer content on [11C]ABP688 binding potential in humans
- 209 Downloads
To determine how the low-affinity (Z)-isomer of the radiotracer [11C]ABP688 affects binding potential values in vivo in humans.
High-resolution [11C]ABP688 PET scans were acquired on 74 healthy volunteers (25 male, 49 female, mean age 20 ± 3.0). The relative contents of (E)- and (Z)-isomers were determined prior to injection using analytical high-performance liquid chromatography [rt(E) = 10 min, rt(Z) = 8.5 min]. Mean binding potential [BPND = fND * (Bavail/KD)] values were calculated in the striatum, limbic regions, and prefrontal cortex using the simplified reference tissue model with cerebellar grey matter as reference.
Mean ± SD (E)-isomer content in [11C]ABP688 production was 92 ± 3.8% (range 78–97%). Percent (E)-isomer was positively correlated with BPND in the striatum (ρ = 0.28, p = 0.015) and limbic regions (ρ = 0.25, p = 0.036). In multiple regression analysis, sex (β = 0.39, p = 0.001) and (E)-isomer content (β = 0.23, p = 0.040) were significant predictors of BPND.
Even modest levels of (Z)-[11C]ABP688 can reduce estimates of tracer binding in vivo. Future studies should use production methods that enrich levels of (E)-[11C]ABP688, report tracer isomer ratios, and account for this factor in their analyses.
KeywordsMetabotropic glutamate receptors mGluR5 Positron emission tomography PET [11C]ABP688
This work was supported by grants from the Canadian Institutes for Health Research MOP-133537 (ML), 119509 (CB and ML), 44072 (JRS) and 97910 (JRS); a grant from the Fonds de Recherche en Santé du Québec (FRQS) ERA-NET (ML); FRQS via fellowships and grants 981055 and 991027 (JRS); the Social Sciences and Humanities Research Council of Canada, grants 839-2000-1008 and 410-99-1048 (JRS); and the Fonds de recherche du Québec – Société et culture, grants 2002-RS-79238 and 2009-RG-124779 (JRS).
Compliance with ethical standards
The authors declare that they have no conflict of interest. All procedures performed in studies involving human participants were in accordance with the ethical standards of the Research Ethics Board of the Montreal Neurological Institute, McGill University and the Ethics Committee of the CHU Sainte-Justine Research Center, and with the 1964 Helsinki Declaration and its later amendments.
Informed consent was obtained from all individual participants included in the study. This article does not contain any studies with animals performed by any of the authors.
- 2.Ametamey SM, Kessler LJ, Honer M, Wyss MT, Buck A, Hintermann S, et al. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J Nucl Med. 2006;47:698–705.Google Scholar
- 6.Smart K, Cox SML, Scala SG, Tippler M, Jaworska N, Boivin M, et al. High resolution [11C]ABP688 imaging of mGluR5 in healthy volunteers: sex differences and test-retest variability. Poster presentation at the XII International Symposium of Functional Neuroreceptor Mapping of the Living Brain, London, United Kingdom; 2018.Google Scholar
- 9.DuBois JM, Rousset OG, Rowley J, Porras-Betancourt M, Reader AJ, Labbe A, et al. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET. Eur J Nucl Med Mol Imaging. 2016;43:152–62.CrossRefGoogle Scholar